About
Cancer Immunotherapies
Areas of Focus
Categories
Virus Technology
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
122
By Phase
PHASE1: 1PHASE1/PHASE2: 1
By Status
TERMINATED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT04990479Lead Sponsor
Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma
PHASE1Terminated
7 participants
Started: Jun 11, 2021 · Completed: Mar 5, 2024
NCT04041310Lead Sponsor
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
PHASE1/PHASE2Active, not recruiting
115 participants
Started: Oct 21, 2019 · Completed: Oct 30, 2026
Locations (1)
Headquarters
Rome, Italy
Map
Loading map...